vTv Therapeutics Inc. (VTVT)
NASDAQ · Healthcare
vTv Therapeutics Inc. Shareholder Equity 2013–2025
vTv Therapeutics Inc. annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- vTv Therapeutics Inc. shareholder equity as of December 31, 2025: 64.4M, a 428.22% increase year-over-year.
- vTv Therapeutics Inc. shareholder equity for 2025 were 64.4M, a 428.22% increase from 2024.
- vTv Therapeutics Inc. shareholder equity for 2024 were 12.2M, a 149.43% decrease from 2023.
- vTv Therapeutics Inc. shareholder equity for 2023 were -24.7M, a 129.80% increase from 2022.
- vTv Therapeutics Inc. shareholder equity for 2022 were -10.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| vTv Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $64 |
| 2024 | $12 |
| 2023 | $-25 |
| 2022 | $-11 |
| 2021 | $-10 |
| 2020 | $-80 |
| 2019 | $-49 |
| 2018 | $-83 |
| 2017 | $-151 |
| 2016 | $-91 |
| 2015 | $-78 |
| 2014 | $-499 |
vTv Therapeutics Inc. Shareholder Equity — FAQ
vTv Therapeutics Inc. (VTVT) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VTVT's shareholder equity history?
The chart and table above show vTv Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.